The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial.

PubWeight™: 0.75^‹?›

🔗 View Article (PMID 26747037)

Published in BMJ Open on January 08, 2016

Authors

Juuso I Blomster¹, Mark Woodward², Sophia Zoungas³, Graham S Hillis¹, Stephen Harrap⁴, Bruce Neal¹, Neil Poulter⁵, Giuseppe Mancia⁶, John Chalmers¹, Rachel Huxley⁷

Author Affiliations

1: The George Institute for Global Health, Sydney, New South Wales, Australia.
2: The George Institute for Global Health, Sydney, New South Wales, Australia Nuffield Department of Population Health, The George Institute for Global Health, University of Oxford, Oxford, UK Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland, USA.
3: The George Institute for Global Health, Sydney, New South Wales, Australia School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
4: University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia.
5: Imperial College and St Mary's Hospital, London, UK.
6: University of Milan-Bicocca and Instituto Auxologico Italiano, Milan, Italy.
7: The George Institute for Global Health, Sydney, New South Wales, Australia School of Public Health, Curtin University, Perth, Western Australia, Australia.

Associated clinical trials:

Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in High Risk Patients With Type 2 Diabetes | NCT00145925

Articles citing this ↘

Cigarette Smoking, Diabetes, and Diabetes Complications: Call for Urgent Action. Curr Diab Rep (2017) 0.75

Articles cited by this ↗

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet (2007) 14.96

Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ (2005) 6.83

Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet (2011) 5.33

Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes. Lancet (2014) 3.72

Study rationale and design of ADVANCE: action in diabetes and vascular disease--preterax and diamicron MR controlled evaluation. Diabetologia (2001) 3.33

Smoking as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 81 cohorts, including 3,980,359 individuals and 42,401 strokes. Stroke (2013) 1.11

Effects of cigarette smoking on fasting triglyceride, total cholesterol, and HDL-cholesterol in women. Am Heart J (1983) 1.09

Trends in cigarette smoking among US adults with diabetes: findings from the Behavioral Risk Factor Surveillance System. Prev Med (2004) 1.05

Cigarette smoking, health status, socio-economic status and access to health care in diabetes mellitus: a cross-sectional survey. BMC Health Serv Res (2003) 1.03

Excess risk of mortality and cardiovascular events associated with smoking among patients with diabetes: meta-analysis of observational prospective studies. Int J Cardiol (2012) 1.00

Self-reported smoking, cigarette yields and inhalation biochemistry related to the incidence of coronary heart disease: results from the Scottish Heart Health Study. J Epidemiol Biostat (1999) 0.93

The influence of physical activity on vascular complications and mortality in patients with type 2 diabetes mellitus. Diabetes Obes Metab (2013) 0.90

Lifestyle factors and mortality risk in individuals with diabetes mellitus: are the associations different from those in individuals without diabetes? Diabetologia (2013) 0.88